Defence Therapeutics Inc.

CNSX:DTC Stock Report

Market Cap: CA$28.7m

Defence Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

CNSX:DTC Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
15 Nov 24SellCA$285Carrie CesaroneIndividual500CA$0.57
07 Jun 24BuyCA$2,850Patrick MeagherIndividual2,500CA$1.14
29 May 24BuyCA$7,682Patrick MeagherIndividual6,600CA$1.18
23 May 24BuyCA$10,625Kwin GrauerIndividual8,500CA$1.25

Insider Trading Volume

Insider Buying: DTC insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of DTC?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders2,291,1004.8%
General Public45,482,27095.2%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 5 shareholders own 4.8% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
3.35%
Sebastien Plouffe
1,600,000CA$960.0k0%no data
0.79%
Patrick Meagher
379,100CA$227.5k0%no data
0.4%
Sarkis Meterissian
192,000CA$115.2k0%no data
0.15%
Moutih Rafei
70,000CA$42.0k0%no data
0.1%
Simon Beaudoin
50,000CA$30.0k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/15 06:44
End of Day Share Price 2025/01/15 00:00
Earnings2024/09/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Defence Therapeutics Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution